Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cognate BioServices, a Charles River Company logo — Your CDMO Partner from Concept to Commercial for Cell & Gene...

Cognate BioServices, a Charles River Company

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Founded 2002 United States Memphis, United States 81 employees Series B Biotechnology, Health Care +1

General Information

Company Name Cognate BioServices, a Charles River Company
Founded Year 2002
Location United States Memphis, United States +2
Founders / Decision Makers
Team member
Employees 81
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Series B
Social

Get notified when Cognate BioServices, a Charles River Company moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cognate BioServices, a Charles River Company

Cognate BioServices, founded in 2002, is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. The company's slogan, "Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products," encapsulates its mission. With a focus on providing a broad range of commercialization services to regenerative medicine, cellular immunotherapy, and advanced cell therapy companies, Cognate offers a unique combination of custom services across all points of clinical and commercial development. This includes early preclinical studies, mid-phase trials, product scale-up, later-stage clinical trials, and bridging into commercial manufacturing. Based in the United States, Cognate BioServices has garnered attention with its most recent Series B investment on 21 January 2020. Noteworthy investors in this round included EW Healthcare Partners and Medivate Partners. As an organization that prides itself on its quality and experience, Cognate applies the know-how and expertise of its business, scientific, and technical teams to successfully develop autologous and allogeneic products across multiple cell-based technology platforms, from start to finish. With a strong focus on biotechnology, health care, and manufacturing industries, Cognate BioServices continues to play a pivotal role in advancing cell and gene therapies for the betterment of medical science.

Taxonomy: CDMO, contract development and manufacturing organization, cell therapy, gene therapy, regenerative medicine, immunotherapy, cGMP manufacturing, autologous products, allogeneic products, cell-based technology, preclinical studies, clinical trials, commercial development, biopharmaceuticals, scientific expertise

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 2
Investor
•••• •••• 		21 Jan 2020
Venture Round •••••• 1 •••• •••• 26 Aug 2019
Venture Round •••••• 2
Investor Investor
20 Feb 2018

Cognate BioServices, a Charles River Company Alternatives & Competitors

Cognate BioServices, a Charles River Company vs
Cognate BioServices
Cognate BioServices

Cognate BioServices is a contract development and manufacturing organization for cell and gene-media...

Cognate BioServices, a Charles River Company vs
Cellares
Cellares United States

Accelerating Access to Life-Saving Cell Therapies

Series D
327 employees
Biotechnology, Pharmaceutical
Compare Cognate BioServices, a Charles River Company vs Cellares
Cognate BioServices, a Charles River Company vs
Aspire Health Science
Aspire Health Science United States

Your contract manufacturing partner; committed to the advancement of promising cellular therapies -...

1 employees
Biotechnology, Life Sciences
Also compare with: Cognate BioServices, a Charles River Company vs RoslinCT RoslinCT Cognate BioServices, a Charles River Company vs Tmunity Therapeutics Tmunity Therapeutics

FAQ About Cognate BioServices, a Charles River Company

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products
Cognate BioServices, a Charles River Company was founded in 2002.
Cognate BioServices, a Charles River Company is headquartered in Memphis, United States.
Cognate BioServices, a Charles River Company operates in the following industries: Biotechnology, Health Care, Manufacturing.
Cognate BioServices, a Charles River Company has approximately 81 employees.
Cognate BioServices, a Charles River Company has completed 3 funding rounds. The latest funding stage is Series B.
Top alternatives and competitors to Cognate BioServices, a Charles River Company include Cognate BioServices, Cellares, Aspire Health Science, RoslinCT, Tmunity Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cognate BioServices, a Charles River Company and Cognate BioServices are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cognate BioServices, a Charles River Company and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy